Italy· 043604038
OVIXAN*crema derm 100 g 1 mg/g
A corticosteroids, potent (group iii) product containing mometasone, registered in Italy by ABIOGEN PHARMA SpA, on the national reimbursement list. The same ATC class is registered in 2 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Mometasone is registered in 2 of 19 countries.
Countries holding a registration under ATC D07AC (corticosteroids, potent (group iii)), each read from that country’s own register.
- This record: Italy
- 2 of them publish a price we can compare per daily dose
Mometasone · ATC D07AC
2 / 19 countries
- Italyprice
- United Statesprice
The record
At a glance
- Active substance
- Mometasone
- Manufacturer
- ABIOGEN PHARMA SpA
- Country
- Italy (IT)
- ATC code
- D07AC
- ATC class
- Corticosteroids, potent (group III)
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic043604038OVIXAN*crema derm 100 g 1 mg/gEUR 17.96
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mometasone in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAsmanex 200micrograms/dose TwisthalerOrganon Pharma (UK) Ltd
- United StatesallergyCVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED
- PolandAleric SprayUS Pharmacia Sp. z o.o.
- GermanyAllergo-MomelindDoppelherz Pharma Gmbh
- CzechiaASMANEXN.V. Organon, Oss
- SpainASMANEX TWISTHALER 200 microgramos POLVO PARA INHALACIONOrganon Salud S.L.
- SwedenAphiahsone 50 mikrogram/dos Nässpray, suspensionGlenmark Arzneimittel GmbH
- NetherlandsBemrist Breezhaler 125 microgram/127,5 microgram inhalatiepoeder in harde capsulesNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Asmanex Twisthaler, Elocon
- Belgium · Asmanex Twisthaler, Elocom
- Bulgaria · Блоктимо, Елоком
- Cyprus · Elocon, Movesan
- Czechia · Asmanex, Elocom
- Germany · Allergo-Momelind, Asmanex Twisthaler
- Denmark · Aphiahsone, Asmanex Twisthaler
- Estonia · Breso, Elocon
- Spain · Asmanex Twisthaler, Elocom
- Finland · Asmanex Twisthaler, Demoson
- France · Asmanex Twisthaler, Mometasone Arrow
- United Kingdom (Northern Ireland) · Asmanex Twisthaler, Clarinaze Allergy Control
- Greece · Asmanex Twisthaler, Elocon
- Croatia · Elocom, Momanose
- Hungary · Azocutan, Elocom
- Ireland · Asmanex Twisthaler, Elocon
- Iceland · Elocon, Kalmente
- Lithuania · Breso, Elocon
- Luxembourg · Elocom, Monovo
- Latvia · Breso, Elocon
- Malta · Elocon, Nasonex
- Netherlands · Elocon, Elocon Vet
- Norway · Asmanex Twisthaler, Elocon
- Poland · Aleric Spray, Edelan
- Portugal · Asmanex Twisthaler, Desdek
- Romania · Elocom, Furoat De Mometazonă Cipla
- Sweden · Aphiahsone, Asmanex Twisthaler
- Slovenia · Asmanex Twisthaler, Elocom
- Slovakia · Asmanex, Elocom
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ab22f7d1-035f-4c8e-9bee-00177c01bdaf GET /v1/drugs/ab22f7d1-035f-4c8e-9bee-00177c01bdaf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 17.96,
"source": "aifa",
"currency": "EUR",
"strength": "MOMETASONE 1MG/G 100G CREMA USO DERMATOLOGICO",
"substance": "Mometasone",
"equivalence_group": "JEE",
"transparency_flag": null
}See everything about mometasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.